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Introduction {#s1}
============

The magnifying narrow-band imaging (M-NBI) is useful in the differential diagnosis between early gastric carcinoma and gastritis [@pone.0100857-Yao1]--[@pone.0100857-Kato1], in determination of the lateral extent of differentiated gastric cancer to plan endoscopic therapy [@pone.0100857-Yao3]--[@pone.0100857-Kiyotoki1], and in visualization of clear contrast within the capillary pattern and the crypt pattern on the mucosa [@pone.0100857-Gono1], [@pone.0100857-Gono2]. M-NBI is more accurate for diagnosing gastric cancers than is conventional white-light imaging, magnifying white-light imaging, or magnifying chromoendoscopy [@pone.0100857-Ezoe1], [@pone.0100857-Zhang1], [@pone.0100857-Tao1]. Yao et al proposed a simple and systematic classification system (vessels plus surface classification system: VSCS) based on the microvascular pattern (MVP), microsurface pattern (MSP), and demarcation line (DL). If the endoscopic findings of M-NBI satisfy the diagnostic criteria of the VSCS, there is a very high possibility that the lesion is early carcinoma [@pone.0100857-Yao4], [@pone.0100857-Miwa1], [@pone.0100857-Yao5].

We usually observe gastric lesions with both moving and still images during endoscopic observation. M-NBI including moving images was shown to be more accurate than conventional white-light imaging for diagnosing small gastric mucosal cancers on site [@pone.0100857-Ezoe2], [@pone.0100857-Yamada1]. Moving images can be thought of as a combination of a very large number of still images and provide an overwhelmingly greater amount of information compared with individual still images. In contrast, we usually use only still images for education, learning, and re-examination for diagnosis after observation because preparing moving images requires much more time and effort and because evaluating still images is simpler compared with the required playback of moving images. It is uncertain whether moving M-NBI images have any additional benefits in diagnosis compared with still images or whether learning to interpret moving M-NBI images is useful. We expected an additional effect of moving images in M-NBI diagnosis of cancer and non-cancer, and thus conducted this study. If there is a sufficient additional effect of moving images, it will be necessary to use moving images not only for diagnosis, but also for learning.

In this exploratory study, we compared the diagnostic accuracy of still M-NBI images only with that of both still and moving images, and attempted to identify the additional benefits of moving M-NBI images in terms of diagnostic accuracy.

Patients/Materials and Methods {#s2}
==============================

The protocols for this trial and supporting CONSORT checklist are available as supporting information; see [Checklist S1](#pone.0100857.s009){ref-type="supplementary-material"} and [Protocols S1](#pone.0100857.s010){ref-type="supplementary-material"} and [S2](#pone.0100857.s011){ref-type="supplementary-material"}.

Study design and participating endoscopists {#s2a}
-------------------------------------------

This prospective multicenter study included the performances of 34 endoscopists with various levels of experience from 10 different institutions in Japan in accordance with the CONSORT 2010 Statement [@pone.0100857-Schulz1] and the Declaration of Helsinki. All participants aimed at mastery of the VSCS used in conjunction with M-NBI and were not limited in terms of their relative experience with the M-NBI procedure. Participants were first tested using still images only (still image test) within 2 weeks, and were then tested 1 month later using both still and moving images (moving image test) within 2 weeks ([Figure 1](#pone-0100857-g001){ref-type="fig"}). We evaluated the diagnostic accuracy, sensitivity, and specificity of both tests. Participants could observe the images any number of times within each answer period. They provided the following information by questionnaire before the study: board certification by the Japan Gastroenterological Endoscopy Society (JGES), years of experience with upper gastrointestinal endoscopy, number of upper gastrointestinal endoscopy procedures, number of M-NBI procedures, and number of M-NBI procedures in the previous month. We divided the participants into 2 groups and examined each using the questionnaire results in subgroup analysis.

![Flow chart of enrollment and analysis records.](pone.0100857.g001){#pone-0100857-g001}

Endoscopy system {#s2b}
----------------

The subepithelial microvascular architecture and the mucosal microsurface structure can be visualized in high contrast in the NBI system [@pone.0100857-Gono1], [@pone.0100857-Gono2]. For magnification endoscopy with NBI and upper gastrointestinal tract magnifying endoscopy (GIF-H260Z; Olympus Medical Systems, Tokyo, Japan), a video processor (EVIS LUCERA Olympus CV-260SL; Olympus Medical Systems) and a light source (EVIS LUCERA Olympus CLV-260SL; Olympus Medical Systems) were used. The structure enhancement of the endoscopic video processor was set to B-mode level 8 for M-NBI. The color mode was fixed at level 1. To obtain stable endoscopic images at maximal magnification, a black soft hood (MAJ-1990 for GIF-H260Z; Olympus Medical Systems) was installed at the tip of the magnification endoscope. Moving images were recorded by a DVD recorder (Vardia RD-E304K; Toshiba, Tokyo, Japan).

Endoscopic images {#s2c}
-----------------

Still and moving M-NBI images of undiagnosed gastric lesions were recorded and evaluated based on the VSCS by an expert endoscopist (H.D.) prior to the study. We selected only M-NBI images without non-magnifying NBI and white-light endoscopy imaging to avoid affecting the endoscopists\' judgment. Lesions with biopsy scars were not used for the test because the diagnosis may have been influenced by the scar. In all cases, the test results were considered to fulfill the VSCS diagnostic criteria. Also, the expert endoscopic diagnoses were consistent with the pathological diagnoses in all cases.

The 40 questions of each test involved cancerous lesions (n = 21, 17 lesions were well differentiated adenocarcinoma dominant and 4 lesions were moderately differentiated adenocarcinoma dominant), noncancerous lesions (n = 19, 2 lesions were low-grade adenoma, 16 lesions were chronic gastritis, and 1 lesion was xanthoma), elevated lesions (n = 10), non-elevated (flat or depressed) lesions (n = 30), upper stomach lesions (n = 5), middle stomach lesions (n = 18), lower stomach lesions (n = 17), \<10-mm lesions (n = 21), and ≥10-mm lesions (n = 19) ([Table 1](#pone-0100857-t001){ref-type="table"}). The still image test included 5 to 8 M-NBI images, and the moving image test included 39 to 66 seconds per question. All pictures used for the still image test were contained in the moving image test and could be seen by pausing the moving image test. The moving images did not stop other than when viewed in the still image test. [Figures 2](#pone-0100857-g002){ref-type="fig"} and [3](#pone-0100857-g003){ref-type="fig"} show representative endoscopic still images.

![Cancerous lesion: Within a DL (arrows), irregular MVP and irregular MSP are noted.](pone.0100857.g002){#pone-0100857-g002}

![Non-cancerous lesion (gastritis): Absent DL, regular MVP, and regular MSP are noted.](pone.0100857.g003){#pone-0100857-g003}

10.1371/journal.pone.0100857.t001

###### Characteristics of 40 Gastric Lesions Used in Both Tests.

![](pone.0100857.t001){#pone-0100857-t001-1}

                                                                              No.    \%
  ------------------- ----------- ------------------------------------------ ----- ------
  Histological type     Cancer                                                21    52.5
                                      Well differentiated adenocarcinoma      17    42.5
                                   Moderately differentiated adenocarcinoma    4    10.0
                       Noncancer                                              19    47.5
                                              Low-grade adenoma                2    5.0
                                              Chronic gastritis               16    40.0
                                                   Xanthoma                    1    2.5
  Elevation               Yes                                                 10    25.0
                          No                                                  30    75.0
  Tumor location         Upper                                                 5    12.5
                        Middle                                                18    45.0
                         Lower                                                17    42.5
  Size                  \<10 mm                                               21    52.5
                        ≥10 mm                                                19    47.5

Diagnostic criteria for M-NBI {#s2d}
-----------------------------

According to the diagnostic criteria of the VSCS, namely (1) the presence of an irregular MVP with a DL or (2) the presence of an irregular MSP with a DL, a case was defined as cancerous when at least one of the findings in (1) or (2) was present and as noncancerous when these findings were absent [@pone.0100857-Yao4]. We set the endoscopic diagnostic grade according to certainty: grade 1, "noncancerous," with a high degree of confidence; grade 2, "noncancerous," with a low degree of confidence; grade 3, "indeterminate," classified as "noncancerous"; grade 4, "cancerous," with a low degree of confidence; grade 5, "cancerous," with a high degree of confidence [@pone.0100857-Yao5].

Diagnosis of pathology {#s2e}
----------------------

The diagnostic pathology criteria were based on the revised Vienna classification [@pone.0100857-Schlemper1], [@pone.0100857-Schlemper2]. Category 4 (C4) was defined by mucosal high-grade neoplasia; 4.1 by high-grade dysplasia/adenoma; 4.2 by noninvasive carcinoma (carcinoma in situ); and 4.3 by intramucosal carcinoma, and Category C5 was defined by submucosal tumor invasion, which were diagnosed as cancer. C1 (negative for neoplasia), C2 (indefinite for neoplasia), and C3 (mucosal low-grade neoplasia, or low-grade dysplasia/adenoma) were diagnosed as noncancerous lesions. Two pathologists assigned the postoperative pathological diagnoses, and the results were double-checked in all cases.

Diagnosis of DL, MVP, and MSP {#s2f}
-----------------------------

The diagnosis of DL, MVP, and MSP was determined by an expert endoscopist according to VSCS. DL was diagnosed as present or absent, and MVP and MSP were diagnosed as regular, irregular, or absent. DL of each test involved 30 present and 10 absent cases. MVP of each test involved 14 regular, 21 irregular, and 5 absent cases. MSP of each test involved 14 regular, 20 irregular, and 6 absent cases ([Table 2](#pone-0100857-t002){ref-type="table"}).

10.1371/journal.pone.0100857.t002

###### M-NBI findings of 40 Gastric Lesions Used in Both Tests.

![](pone.0100857.t002){#pone-0100857-t002-2}

                                       No.    \%
  ----------------------- ----------- ----- ------
  Demarcation Line          Present    30    75.0
                            Absent     10    25.0
  Microvascular pattern     Regular    14    35.0
                           Irregular   21    52.5
                            Absent      5    12.5
  Microsurface pattern      Regular    14    35.0
                           Irregular   20    50.0
                            Absent      6    15.0

Outcome measures {#s2g}
----------------

The main outcome was a difference in the diagnostic accuracy of cancerous versus noncancerous lesions between the still image test and the moving image test. The secondary outcomes were (1) a difference in the sensitivity and specificity of the diagnosis of cancerous versus noncancerous lesions between both tests, (2) a difference in the accuracy of the diagnosis of DL, MVP, and MSP between both tests, (3) subgroup analysis of the endoscopic findings of the lesion, including macroscopic type, and (4) subgroup analysis of the characteristics of the endoscopists, including whether they were board-certified by the JGES and their relative experience with the M-NBI procedure.

Statistical analysis {#s2h}
--------------------

The paired t test was used to determine differences in diagnostic accuracy between the still image test and the moving image test. Pearson\'s chi-square test was used to determine differences in sensitivity and specificity between both tests. All statistical indices were determined to be significant at a *P* value of \<0.05. The Benjamini--Hochberg procedure was used in subgroup analyses to reduce the chances of obtaining false-positive results. The endoscopic diagnostic grade according to the certainty of each test was evaluated using receiver operating characteristic (ROC) curve analysis, which correlates sensitivity and (1 -- specificity). In addition, the difference in the area under the curve (AUC) values was determined by the paired t test. All analyses were performed with the use of SPSS statistical software version 10.5 J for Windows (SPSS Inc., Chicago, IL).

Ethics statement {#s2i}
----------------

Written informed consent was obtained, and the institutional review board (IRB) of Ishikawa Prefectural Central Hospital approved the study. After that, IRB of each participating hospital (Saiseikai Kanazawa Hospital, Kanazawa Municipal Hospital, Kanazawa Medical Center, Kanazawa Social Insurance Hospital, KKR Hokuriku Hospital, Kanazawa Red Cross Hospital, Komatsu Municipal Hospital, Suzu General Hospital, Sangane Clinic, and Kanazawa University) approved the study. This study has been registered in the UMIN Clinical Trials Registry System as trial ID UMIN-CTR000008048.

Results {#s3}
=======

Thirty-four endoscopists were analysed, and no endoscopists were excluded. There was no significant difference in the diagnostic accuracy of cancerous versus noncancerous lesions between the still and moving image tests (59.9% versus 61.5%, respectively; *P* = 0.272). There were also no significant differences in the sensitivity (53.4% versus 55.9%, respectively; *P* = 0.312) or specificity (67.0% versus 67.6%, respectively; *P* = 0.812) of the diagnosis of cancerous versus noncancerous lesions between the still and moving image tests ([Table 3](#pone-0100857-t003){ref-type="table"}, [Table S1](#pone.0100857.s001){ref-type="supplementary-material"}). The raw data in each endoscopist and each question were shown in [Table S2](#pone.0100857.s002){ref-type="supplementary-material"} (still image test) and [Table S3](#pone.0100857.s003){ref-type="supplementary-material"} (moving image test). The raw data of endoscopic experience and diagnostic accuracy in each endoscopist were shown in [Table S4](#pone.0100857.s004){ref-type="supplementary-material"}. And the raw data of diagnostic accuracy in each question were shown in [Table S5](#pone.0100857.s005){ref-type="supplementary-material"}. [Table 4](#pone-0100857-t004){ref-type="table"} shows the endoscopic diagnoses for all lesions according to the degree of certainty in the still and moving image tests. ROC curves were generated as shown in [Figure 4](#pone-0100857-g004){ref-type="fig"}. No significant difference was found between the AUC values of the still and moving image tests (0.629 versus 0.649, respectively; *P* = 0.303).

![Receiver operating characteristic (ROC) curve of the endoscopic diagnostic grades is according to the certainty of each test correlated with sensitivity and (1 -- specificity).\
The area under the curve (AUC) was as follows: still image test 0.629, moving image test 0.649 (*P* = 0.303).](pone.0100857.g004){#pone-0100857-g004}

10.1371/journal.pone.0100857.t003

###### Diagnostic Accuracy, Sensitivity, and Specificity of Cancerous versus Noncancerous Lesions of Still Image Test versus Moving Image Test in Overall 34 Endoscopists.

![](pone.0100857.t003){#pone-0100857-t003-3}

                 Still Image Test, % \[95% C.I.\]   Moving Image Test, % \[95% C.I.\]   *P* value
  ------------- ---------------------------------- ----------------------------------- -----------
  Accuracy             59.9 \[56.1--63.6\]                 61.5 \[57.1--65.8\]            .272
  Sensitivity          53.4 \[48.0--58.7\]                 55.9 \[49.2--62.6\]            .312
  Specificity          67.0 \[61.9--72.1\]                 67.6 \[61.4--73.8\]            .812

10.1371/journal.pone.0100857.t004

###### Endoscopic Diagnoses for All Lesions according to Grade of Certainty in Still and Moving Image Tests.

![](pone.0100857.t004){#pone-0100857-t004-4}

           Still Image Test   Moving Image Test                     
  ------- ------------------ ------------------- ------ ----- ----- ------
  1               66                 141          207    55    123   178
  2              163                 186          349    161   218   379
  3              104                 106          210    98    96    194
  4              265                 159          424    265   158   423
  5              116                 54           170    135   51    186
  Total          714                 646          1360   714   646   1360

\*Grade 1: "noncancerous," with high degree of confidence; grade 2: "noncancerous," with low degree of confidence; grade 3: "indeterminate," classified as "noncancerous"; grade 4: "cancerous," with low degree of confidence; grade 5: "cancerous," with high degree of confidence.

There were no significant differences in the diagnostic accuracy of DL (65.4% versus 65.5%, respectively; *P* = 0.955), MVP (56.7% versus 56.9%, respectively; *P* = 0.866), or MSP (48.1% versus 50.9%, respectively; *P* = 0.115) ([Table 5](#pone-0100857-t005){ref-type="table"}, [Table S6](#pone.0100857.s006){ref-type="supplementary-material"}).

10.1371/journal.pone.0100857.t005

###### Diagnostic Accuracy of Vessels Plus Surface Classification System in Still Image Test versus Moving Image Test by All 34 Endoscopists.

![](pone.0100857.t005){#pone-0100857-t005-5}

                           Accuracy, % \[95% C.I.\]        *P* value       
  ----------------------- -------------------------- --------------------- ------
  Demarcation Line           65.4 \[62.0--68.9\]      65.5 \[61.4--69.6\]   .955
  Microvascular pattern      56.7 \[52.7--60.8\]      56.9 \[53.2--60.6\]   .866
  Microsurface pattern       48.1 \[44.5--51.8\]      50.9 \[46.6--55.1\]   .115

Diagnostic accuracy showed no significant difference between the still and moving image tests in the subgroups of endoscopic findings of the lesions. There was no significant difference in the macroscopic type of elevated lesions (57.9% versus 60.3%, respectively; *P* = 0.389), nonelevated lesions (60.5% versus 61.9%, respectively; *P* = 0.405), upper stomach lesions (65.3% versus 67.1%, respectively; *P* = 0.646), middle stomach lesions (57.7% versus 59.2%, respectively; *P* = 0.630), lower stomach lesions (60.6% versus 62.3%, respectively; *P* = 0.538), \<10-mm lesions (62.6% versus 65.8%, respectively; *P* = 0.228), and ≥10-mm lesions (56.8% versus 56.7%, respectively; *P* = 0.951) ([Table 6](#pone-0100857-t006){ref-type="table"}, [Table S7](#pone.0100857.s007){ref-type="supplementary-material"}).

10.1371/journal.pone.0100857.t006

###### Diagnostic Accuracy of Still Image Test versus Moving Image Test in the Subgroups of Endoscopic Findings.

![](pone.0100857.t006){#pone-0100857-t006-6}

                                       Accuracy, % \[95% C.I.\]        *P* value       
  ---------------- ------------------ -------------------------- --------------------- ------
  Elevation           Yes (n = 10)       57.9 \[40.6--75.3\]      60.3 \[46.6--74.0\]   .389
                      No (n = 30)        60.5 \[52.6--68.4\]      61.9 \[53.8--69.9\]   .405
  Tumor location     Upper (n = 5)       65.3 \[38.8--91.8\]      67.1 \[45.5--88.6\]   .646
                    Middle (n = 18)      57.7 \[47.6--67.7\]      59.2 \[48.6--69.7\]   .630
                     Lower (n = 17)      60.6 \[48.1--73.0\]      62.3 \[51.1--73.5\]   .538
  Size              \<10 mm (n = 21)     62.6 \[53.6--71.6\]      65.8 \[57.3--74.4\]   .228
                    ≥10 mm (n = 19)      56.8 \[45.3--68.3\]      56.7 \[46.0--67.3\]   .951

Diagnostic accuracy was lower in the still image test than that in the moving image test among the subgroup of endoscopists who were board-certified by the JGES (62.7% versus 66.5%, respectively; *P* = 0.041), the subgroup of endoscopists who had experienced more than 200 M-NBI procedures (65.6% versus 68.9%, respectively; *P* = 0.049), and the subgroup of endoscopists who had experienced more than 15 M-NBI procedures in the previous month (65.1% versus 69.3%, respectively; *P* = 0.037). However, after applying the Benjamini--Hochberg procedure, the significant differences disappeared. Diagnostic accuracy showed no significant differences between the subgroups (the number of upper gastrointestinal endoscopy procedures and the years of experience of upper gastrointestinal endoscopy) ([Table 7](#pone-0100857-t007){ref-type="table"}, [Table S8](#pone.0100857.s008){ref-type="supplementary-material"}).

10.1371/journal.pone.0100857.t007

###### Diagnostic Accuracy of Still Image Test versus Moving Image Test in the Subgroups of Endoscopist Characteristics.

![](pone.0100857.t007){#pone-0100857-t007-7}

                                                                                       Accuracy, % \[95% C.I.\]        *P* value       
  ----------------------------------------------------------------- ----------------- -------------------------- --------------------- --------
  Board-Certified by JGES[\*](#nt102){ref-type="table-fn"}            Yes (n = 15)       62.7 \[58.5--66.8\]      66.5 \[62.8--70.2\]    .041
                                                                       No (n = 19)       57.8 \[51.9--63.6\]      57.5 \[50.5--64.5\]    .908
  Years of experience performing upper gastrointestinal endoscopy      ≥8 (n = 17)       62.6 \[59.2--66.1\]      65.2 \[61.2--69.4\]    .161
                                                                      \<8 (n = 17)       57.2 \[50.5--63.9\]      57.6 \[49.9--65.4\]    .856
  Number of cases of upper gastrointestinal endoscopy                ≥5000 (n = 20)      61.9 \[57.1--66.6\]      64.5 \[59.8--69.2\]    .112
                                                                     \<5000 (n = 14)     57.1 \[50.9--63.4\]      57.1 \[48.7--65.6\]   \>.999
  Number of cases of M-NBI procedures                                 ≥200 (n = 18)      65.6 \[60.4--70.7\]      68.9 \[64.2--73.6\]    .049
                                                                     \<200 (n = 16)      53.6 \[50.1--57.1\]      53.1 \[47.7--58.5\]    .858
  Number of cases of M-NBI procedures in the previous month           ≥15 (n = 15)       65.2 \[58.8--71.5\]      69.3 \[63.2--75.5\]    .037
                                                                      \<15 (n = 19)      55.7 \[52.0--59.5\]      55.3 \[50.5--60.0\]    .811

\*Japan Gastroenterological Endoscopy Society.

Discussion {#s4}
==========

In practice, we observe a gastric lesion with moving M-NBI images and reappraise the lesion with still images after the observation. That is to say, we usually diagnose the lesion by utilizing both still and moving images. A moving image is an aggregate of a very large number of still images. The still images provide less information compared with a moving image. As an M-NBI learning tool, preparing moving images requires much more time and effort compared with preparing only still images [@pone.0100857-deLange1], [@pone.0100857-Wurnig1], and checking still images is simple compared with the playback required of moving images [@pone.0100857-deLange1]; thus, we usually use only still images. In general, there are almost no records of moving images when an observer wants to recheck the lesion and when endoscopists other than the observer want to diagnose the lesion. In contrast, with the widespread availability of Internet resources, learning programs with web-based videos are becoming a great tool to improve the diagnostic yield with endoscopy [@pone.0100857-deLange2], [@pone.0100857-DinisRibeiro1], [@pone.0100857-DiasSilva1]. To our knowledge, the difference between still images and moving images has not been adequately evaluated. For ulcerative colitis, for example, the mucosal inflammation might be documented nearly as well with a still image as on a video clip, and so systematic use of still images probably improves the endoscopy reports by adding more objective information about the mucosal inflammation [@pone.0100857-deLange1]. Therefore, we performed the present study to clarify whether only still images are adequate or whether the addition of moving images is required in M-NBI.

In this multicenter study, there were no significant differences in the diagnostic accuracy, sensitivity, and specificity of cancerous versus noncancerous lesions between the still and moving image tests, and the diagnostic superiority of moving images over still images could not be proved. In addition, ROC curves of the two tests were almost identical. Diagnostic accuracy did differ in some subgroup analyses, but the differences were very small and disappeared after applying the Benjamini--Hochberg procedure. Even if the diagnostic superiority of moving images is proven in a future confirmatory trial with a greater number of endoscopists experienced in M-NBI, there may be not enough clinical significance because of the small differences between the 2 tests.

Based on the results of this study, it is likely that sharp still images with the evident feature of the lesion have sufficient information for equivalence with moving images. It is reasonable to concentrate on taking high-quality still images at the time of observation by M-NBI and to obtain a diagnosis from the still images at the time of or after the observation.

It is necessary, however, to consider the use of M-NBI images as a study tool for VSCS learning. It will be important to adequately understand each endoscopic finding of DL, MVP, and MSP when learning VSCS [@pone.0100857-Ito1], [@pone.0100857-Yamada2]. In this multicenter study, there were also no significant differences in the accuracy of the diagnosis of DL, MVP, and MSP between the 2 tests. As a learning tool, there may not be any advantages of moving images. Still images may facilitate better recognition and understanding because they do not move. Moreover, given the large amount of time, effort, and cost associated with preparation of moving images, still images may be preferable to moving images [@pone.0100857-deLange1]. When individuals learn to interpret M-NBI, still images alone are expected to be an adequate learning tool [@pone.0100857-Yamada2], [@pone.0100857-Mabe1], [@pone.0100857-Yoo1].

In this study, the high-quality images were obtained by an expert endoscopist, not by the study participants, and we did not evaluate the recording technique used by the participants. In M-NBI, specific techniques are required to accurately evaluate and record images [@pone.0100857-Yamada2], [@pone.0100857-Mabe1]. Based on these points, we should consider that the participants\' diagnostic accuracy in practice may not agree with the results of this study. Diagnosis using M-NBI cannot be performed well without a photographing technique [@pone.0100857-Yamada2]. We should also aim to further improve photographing techniques.

This study has some limitations. First, no formal sample size was estimated because this study was conducted as an exploratory study. Second, it was a single-arm trial involving a moving image test after a still image test. Third, only one endoscopist evaluated the M-NBI results; thus, the answers to each item (DL, MVP, and MSP) of the VSCS may not be completely accurate. Finally, learning and experience of M-NBI may have been acquired in a 1-month interval of both tests.

In conclusion, our results indicate that the addition of moving M-NBI images to still M-NBI images does not improve the diagnostic accuracy of gastric lesions. Thus focusing on taking sharp still M-NBI images during endoscopic observation and using them for diagnosis is reasonable.
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